Is the cash status a concern going forward? Seems they needed to get more....will it last? When is Phase III due out??
have $40M or so in cash.
burn rate circa 5M per quarter.
Neuvax only cost approx $1000/dose or $11,000/patient. There are 700 patients which equates to $7,700,000. Galena has plenty of money and the interim results will dramatically boost the pps
thanks....was at 1.70 within the past 2 months...think it will dip further soon to buy in therE??